Literature DB >> 29131362

Sex discordance identification following non-invasive prenatal testing.

Ebony J Richardson1, Fergus P Scott1,2, Andrew C McLennan1,3.   

Abstract

OBJECTIVE: The objectives of this study were to characterise genotype-phenotype discordance identified in the routine clinical setting and to explore the associated diagnostic and counselling challenges.
METHOD: Cases were derived from a cohort of pregnant women who attended a multisite specialist prenatal screening and ultrasound service for non-invasive prenatal testing by cell-free DNA analysis and midtrimester fetal morphology assessment.
RESULTS: Seven cases of genotype-phenotype discordance were identified from a cohort of 12 919 women between June 2013 and March 2017 (incidence 1/1845 pregnancies). A variety of disorders of sexual differentiation were subsequently diagnosed.
CONCLUSION: Sex chromosomes are the basis of sexual differentiation during embryonic development. Variations of the traditional XX or XY karyotype may result in conditions where the genotype is discordant with the phenotype. Detection of these conditions in the past typically occurred during adolescence, due to delayed puberty, or during adulthood, due to infertility. With the increasing availability of non-invasive prenatal testing and high-resolution ultrasound, more cases of genotype-phenotype sex discordance are being identified in routine clinical practice during early pregnancy. These discordant results present significant diagnostic and counselling challenges, and their potential should be included in increasingly complex pre-NIPT counselling.
© 2017 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 29131362     DOI: 10.1002/pd.5184

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

1.  Disorders of sexual development with XY karyotype and female phenotype: clinical findings and genetic background in a cohort from a single centre.

Authors:  G Costagliola; M Cosci O di Coscio; B Masini; F Baldinotti; M A Caligo; N Tyutyusheva; M R Sessa; D Peroni; S Bertelloni
Journal:  J Endocrinol Invest       Date:  2020-05-06       Impact factor: 4.256

2.  Prenatal diagnosis of a 46,XY karyotype female fetus with an SRY-associated gonadal dysgenesis, conceived through an intracytoplasmic sperm injection: a case report.

Authors:  Lidiia Zhytnik; Maire Peters; Kadi Tilk; Tiia Reimand; Piret Ilisson; Tiina Kahre; Ülle Murumets; Aivar Ehrenberg; Eva-Liina Ustav; Neeme Tõnisson; Signe Mölder; Hindrek Teder; Kaarel Krjutškov; Andres Salumets
Journal:  BMC Pregnancy Childbirth       Date:  2022-02-05       Impact factor: 3.007

3.  EARLY-ONSET GONADOBLASTOMA IN A 13-MONTH-OLD INFANT WITH 46,XY COMPLETE GONADAL DYSGENESIS IDENTIFIED WITH PRENATAL TESTING: A CASE OF CHROMOSOME 9p DELETION.

Authors:  Meghan E Fredette; Katelyn Cusmano; Chanika Phornphutkul; Jennifer Schwab; Anthony Caldamone; Lisa Swartz Topor
Journal:  AACE Clin Case Rep       Date:  2019-08-14

4.  Discordant sex between fetal screening and postnatal phenotype requires evaluation.

Authors:  Heather M Byers; Whitney Neufeld-Kaiser; Edith Y Chang; Karen Tsuchiya; Erin S Oehler; Margaret P Adam
Journal:  J Perinatol       Date:  2018-11-21       Impact factor: 2.521

5.  Detection of SRY-positive46,XX male syndrome by the analysis of cell-free fetal DNA via non-invasive prenatal testing.

Authors:  Luigia De Falco; Giovanni Savarese; Teresa Suero; Sonia Amabile; Raffaella Ruggiero; Pasquale Savarese; Antonio Fico
Journal:  Clin Case Rep       Date:  2019-09-07

Review 6.  Sex selection and non-invasive prenatal testing: A review of current practices, evidence, and ethical issues.

Authors:  Hilary Bowman-Smart; Julian Savulescu; Christopher Gyngell; Cara Mand; Martin B Delatycki
Journal:  Prenat Diagn       Date:  2019-10-10       Impact factor: 3.050

7.  Fetal Sex Results of Noninvasive Prenatal Testing and Differences With Ultrasonography.

Authors:  Rupin Dhamankar; Wendy DiNonno; Kimberly A Martin; Zachary P Demko; Veronica Gomez-Lobo
Journal:  Obstet Gynecol       Date:  2020-05       Impact factor: 7.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.